Who invested in Reneo Pharmaceuticals?
Reneo Pharmaceuticals's investors include New Enterprise Associates, RiverVest, Pappas Capital and Lundbeckfonden Ventures.
United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$105Mraised across 2 rounds since 2019, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $25M sold, first sale May 2019
From the SEC filings it signed: 4 on the team.
On the board, as filediBali MuralidharEd MathersJohan KordelKenneth HarrisonLon CardonMichael GreyNiall O'DonnellStacey Seltzer
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Reneo Pharmaceuticals's investors include New Enterprise Associates, RiverVest, Pappas Capital and Lundbeckfonden Ventures.
Reneo Pharmaceuticals has raised $105M across 2 rounds since 2019.
Reneo Pharmaceuticals's most recent round was an Undisclosed round of $55M in May 2023.
Its most recent round, $55M in May 2023, is also its largest on record.
Reneo Pharmaceuticals's first round on record, in May 2019, was backed by New Enterprise Associates, RiverVest and Pappas Capital and 1 others.
Reneo Pharmaceuticals's latest named round is an Undisclosed round, in May 2023.
Reneo Pharmaceuticals is based in the United States.
New Enterprise Associates led the Series A in 2019.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.